AZD 2932 – 25 mg

Brand:
Cayman
CAS:
883986-34-3
Storage:
-20
UN-No:
De Minimis - 3077 / 9

AZD 2932 is an inhibitor of VEGFR2, PDGFRβ, CSF1R, c-KIT, and FLT3 receptor tyrosine kinases (IC50s = 4, 8, 100, 9, and 7 nM, respectively).{41214} It also inhibits Pdgfrα phosphorylation (IC50 = 2 nM) in lysates from C6 rat glial tumors grown in athymic mice. AZD 2932 (12.5-50 mg/kg) reduces tumor growth and inhibits Pdgfrβ and Vegfr2 phosphorylation in a 1:1 ratio in a C6 mouse xenograft model. Xenograft models using non-PDGFR expressing tumor cells were insensitive to AZD 2932 treatment.  

 

Available on backorder

SKU: - Category:

Description

A multi-kinase inhibitor (IC50s = 4, 8, 100, 9, and 7 nM for VEGFR2, PDGFRβ, CSF1R, c-KIT, and FLT3 receptor tyrosine kinases, respectively); inhibits Pdgfrα phosphorylation (IC50 = 2 nM) in lysates from C6 rat glial tumors; reduces tumor growth and inhibits Pdgfrβ and Vegfr2 phosphorylation in a 1:1 ratio in a C6 mouse xenograft model


Formal name: 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N-[1-(1-methylethyl)-1H-pyrazol-4-yl]-benzeneacetamide

Synonyms: 

Molecular weight: 447.5

CAS: 883986-34-3

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|PDGFR Family||Product Type|Biochemicals|Kinase Inhibitors|VEGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area